PharmaVoice’s Crystal Ball: The industry’s AI future - Qinecsa
PharmaVoice’s Crystal Ball: The industry’s AI future
- Articles
- January 7, 2025
Thought leadership from Martin Holm-Petersen continues! Qinecsa’s Chief Strategy Officer contributes to PharmaVoice’s 2025 AI Trends Feature.
In his contribution, Martin highlights how working with various AI/ML models is critical in leveraging technology to transform drug discovery and development.
Recent Articles
The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?
- July 28, 2026
Embracing quantitative signal detection methods as a smaller MAH
- June 25, 2026
Real-Time Safety Signals Drive Continuous PV Insight
- May 27, 2026
From Complaint Handling to Active Surveillance
- May 5, 2026
Continuous Safety Surveillance for Medical Devices
- May 5, 2026
Are patient outcomes getting lost in safety data complexity?
- May 5, 2026
PreviousDrug Solutions Podcast: Realizing AI’s Potential
NextJoin Qinecsa at DIA 2025 Pharmacovigilance & Risk Management Strategies Conference